"Fatigue" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.
Descriptor ID |
D005221
|
MeSH Number(s) |
C23.888.369
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fatigue".
Below are MeSH descriptors whose meaning is more specific than "Fatigue".
This graph shows the total number of publications written about "Fatigue" by people in this website by year, and whether "Fatigue" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1996 | 1 | 4 | 5 |
1999 | 1 | 0 | 1 |
2000 | 0 | 3 | 3 |
2001 | 1 | 4 | 5 |
2002 | 3 | 2 | 5 |
2003 | 9 | 5 | 14 |
2004 | 1 | 8 | 9 |
2005 | 3 | 7 | 10 |
2006 | 7 | 9 | 16 |
2007 | 16 | 17 | 33 |
2008 | 8 | 10 | 18 |
2009 | 7 | 11 | 18 |
2010 | 15 | 15 | 30 |
2011 | 9 | 14 | 23 |
2012 | 17 | 19 | 36 |
2013 | 11 | 23 | 34 |
2014 | 18 | 25 | 43 |
2015 | 8 | 15 | 23 |
2016 | 13 | 20 | 33 |
2017 | 12 | 18 | 30 |
2018 | 6 | 15 | 21 |
2019 | 8 | 17 | 25 |
2020 | 8 | 12 | 20 |
2021 | 6 | 22 | 28 |
2022 | 1 | 21 | 22 |
2023 | 1 | 19 | 20 |
2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fatigue" by people in Profiles.
-
Emotional, Behavioral, and Cognitive Symptom Associations With Community Participation in Chronic Traumatic Brain Injury. J Head Trauma Rehabil. 2024 Mar-Apr 01; 39(2):E83-E94.
-
Post-recovery health domain scores among outpatients by SARS-CoV-2 testing status during the pre-Delta period. BMC Infect Dis. 2024 Mar 08; 24(1):300.
-
Reflective Engagement With a Digital Physical Activity Intervention Among People Living With and Beyond Breast Cancer: Mixed Methods Study. JMIR Mhealth Uhealth. 2024 Feb 09; 12:e51057.
-
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies. Oncoimmunology. 2024; 13(1):2290787.
-
Data-driven subgrouping of youths with depression reveals that resilience is associated with higher physical functioning despite high symptom burden in the Texas Youth Depression and Suicide Research Network (TX-YDSRN). J Affect Disord. 2024 Mar 01; 348:353-361.
-
Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial. Lancet Oncol. 2023 Dec; 24(12):1359-1374.
-
Longitudinal perioperative patient-reported outcomes in open compared with minimally invasive hysterectomy. Am J Obstet Gynecol. 2024 Feb; 230(2):241.e1-241.e18.
-
Physical activity interventions for cancer-related fatigue: A scoping review of randomized controlled trials from a Nursing Science Precision Health Model perspective. Nurs Outlook. 2023 Nov-Dec; 71(6):102052.
-
Beyond the symptom: the biology of fatigue. Sleep. 2023 09 08; 46(9).
-
Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial. Neurology. 2023 07 18; 101(3):e238-e252.